Reimbursement
The Center for Medicare and Medicaid Innovation (CMMI) Nov. 26 finalized a new
mandatory payment model that will begin on July 1, 2025 and test whether hospital
performance-based incentive payments or penalties will increase access to kidney
transplants while preserving or enhancing the quality of…
Before the lame-duck session ends and the 118th Congress adjourns, it is essential that federal lawmakers understand the challenges hospitals and health systems face and what is at stake for the patients and communities they represent.
AHA letter urging Congress to act on key priorities in Lame-duck session.
The AHA Aug. 13 commented to the Medicare Payment Advisory Commission in anticipation of the commission’s 2024-2025 cycle.
AHA statement on policies to ensure rural patients continue to receive access to high-quality care.
The AHA’s new Costs of Caring report highlights how hospitals and health systems continue to experience significant financial pressures that challenge their ability to provide 24/7 care for patients and communities.
It is broadly acknowledged that Medicare reimburses hospitals less than the cost of providing care and their reimbursement rates are non-negotiable.
The AHA May 2 released a new report highlighting how hospitals and health systems continue to experience significant financial pressures that challenge their ability to provide 24/7 care for patients and communities.
Health care artificial intelligence action plan defines people, process and technology essentials, ROI, and AI use cases to transform care delivery.
- Leadership
- Patient-Centered Care
- Quality & Patient Safety
- Operational Excellence
- Financial Management
- Artificial Intelligence (AI)
- Leveraging Technology
- Impact of Technology on the Workforce
- ROI
- Reimbursement
- AHA Center for Health Innovation
- Technology Strategy
- Access to Behavioral Health
- Innovation/New Models of Care
The AHA and American Society of Health-System Pharmacists Nov. 14 urged House and Senate leaders to oppose any policies that fail to take into account the costs of safely providing drug administration services to the complex patients that hospitals serve.